RQ-00201894

N/A

Report date: 2024/04/18 11:25:05
NME

Base Information

Drug NameRQ-00201894
Drug Alias NameRQ-00201894
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMotilin receptor agonists
TargetsMotilin receptor
Therapy Area/IndicationsDyspepsiaGastroparesisIleus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Limitid
China Registration ClassN/A

Develop Information

Active CompaniesPfizer Limitid
Inactive CompaniesN/A
Active IndicationsDyspepsiaGastroparesisIleus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A